Education
About Us
Working with TipRanks
Follow Us
Robert Blum Insider Profile
11 Followers
Robert Blum, President & CEO, Director at Cytokinetics, holds 368.35K shares in Cytokinetics (Ticker: CYTK), holds 96.50K shares in Gamida Cell (Ticker: GMDAQ). Most recently, Robert Blum Sold ― shares of Cytokinetics on Mar 07, 2025 for an estimated value of 737.18K.
Robert Blum Cytokinetics (CYTK)President & CEO, Director
Cytokinetics (CYTK)
President & CEO, Director
Ranked #89,631 out of 100,956 Corporate Insiders
Profitable Transactions
15 out of 28 Profitable Transactions
Average Return
-13.70%
Average return per transaction
Time Frame
Compare to
Insider Roles
President & CEO, Director
Roles that Robert Blum holds in companies
Most Profitable Insider Trade
The most profitable trade made by Robert Blum
Robert Blum's Trading History
Cytokinetics
Mar 07, 2025
President & CEO, Director
Informative Sell
737.18K
$16.00M
Gamida Cell
Feb 10, 2023
―
Uninformative Buy
―
$1.54K
List of latest transactions for each holding click on a transaction to see Robert Blum's performance on stock
You May Also Like
Robert Blum insider profile FAQ
What is the percentage of profitable transactions made by Robert Blum?
The percentage of profitable transactions made by Robert Blum is 54%.
What is the average return per transaction made by Robert Blum?
The average return per transaction made by Robert Blum is -13.70%.
What stocks does Robert Blum hold?
Robert Blum holds: CYTK, GMDAQ stocks.
What was Robert Blum’s latest transaction?
Robert Blum latest transaction was an Informative Sell of $737.18K.
What was Robert Blum's most profitable transaction?
Robert Blum’s most profitable transaction was an Informative Sell of CYTK stock on July 31, 2024. The return on the trade was 26.40%.
What is Robert Blum's role in Cytokinetics?
Robert Blum's role in Cytokinetics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.